Aversiveness and Meaningfulness of Uncomfortable Experiences with Edible Cannabis
Stacey Farmer, Melissa N. Slavin, Mallory Loflin, Rachel Luba, Mitch Earleywine
Journal of Psychoactive Drugs July 29, 2019 DOI: 10.1080/02791072.2019.1645371 via OpenAlex
Summary
AI-generated from the abstractCannabis remains the most frequently used illicit drug in the United States, and as legal status has changed, more people use edibles. Among 172 individuals who reported an uncomfortable experience with edible cannabis, 62.9% found the experience at least somewhat meaningful, and 95.2% reported no medical problems. The most common non-medical problem was going to bed early or lying down (75.8%). Most participants (69.2%) said dose was the key contributor to the negative experience. Those who rated the experience as more aversive were less likely to use edibles again, and longer duration of the aversive experience correlated with higher aversiveness. Despite discomfort, the vast majority used edibles again and reported no significant problems.
Study at a glance
| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 172 |
| Population | Individuals who reported an uncomfortable experience with edible cannabis |
| Topics | Cannabis |
| Keywords | Legalization Psychiatry Clinical psychology Medicine |
| Citations | 16 |
| Key finding | Dose was the key contributor to uncomfortable edible cannabis experiences, yet most participants found the experience meaningful and reported no medical problems. |
Abstract
Cannabis remains the most frequently used illicit drug in the United States. As its legal status has changed, more people have turned to oral administration (“edibles”). 172 individuals who reported an uncomfortable experience with edible cannabis completed an online survey. Despite the aversive nature of the experience, 62.9% of the sample reported that the edible experience was at least somewhat meaningful and the majority of participants (95.2%) did not report any medical problems. The most common non-medical problem reported was going to bed early or lying down (75.8%). Most participants (69.2%) reported that dose was the key contributor to their negative experience. Participants who rated the experience as more aversive were less likely to use edibles again, r (167) = − .180, p < . 05. In addition, the duration of the aversive experience correlated positively with aversiveness rating, r (167) = . 244, p < . 05. With increased legalization of cannabis, edible use may rise. Dose seems to be associated with uncomfortable experiences with edible cannabis. Notwithstanding these uncomfortable experiences, the vast majority of the sample used cannabis edibles again, reported that the experience was at least somewhat meaningful, and did not report significant problems associated with the experience.